or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

[x] close
Print Track This Candidate

Public Statements

Senator Richard Blumenthal's Public Statements on Drugs

Richard Blumenthal
Full Name: Richard Blumenthal
Office: U.S. Senate (CT) - Sr, Democratic
First Elected: 11/02/2010
Next Election: 2016
Gender: Male
Family: Wife: Cynthia; 4 Children
Birth Date: 02/13/1946
Birth Place: Brooklyn, NY
Home City: Greenwich, CT

Issue



(clear issue)

Keyword Search

Date Title Location
April 26, 2013 Senators Lautenberg, Durbin, Harkin, and Blumenthal Introduce Legislation to Stop Tobacco Smuggling, Close Tobacco Tax Loopholes, and Increase Federal Tobacco Taxes Washington, DC
March 22, 2013 Letter to Food and Drug Administration (FDA) Commissioner Margaret Hamburg - Develop Tobacco Warning Labels Washington, DC
March 21, 2013 Letter to Margaret Hamburg, U.S. Food and Drug Administration Commissioner - Contaminated Drugs in CT Hospital Washington, DC
Oct. 11, 2012 Letter to The Honorable Eric H. Holder, Jr., The Attorney General Washington, DC
Oct. 8, 2012 Letter to Commissioner Hamburg Hartford, CT
Sept. 21, 2012 Senators Blumenthal, Kohl, Grassley Seek to Protect the Elderly and Taxpayers from Abusive Overprescribing of Antipsychotics Washington, DC
June 26, 2012 Blumenthal Hails Final Passage of Fda Safety and Innovation Act, Highlights 13 Provisions Included in Legislation Washington, DC
June 15, 2012 Letter to the Honorable Tom Harkin, Chairman on the Committee on Health, Education, Labor, and Pensions, the Honorable Michael B. Enzi, Ranking Member Committee on Health, Education, Labor, and Pensions, the Honorable Fred Upton, Chairman on the Committee on Energy and Commerce, and the Honorable Henry A. Waxman Ranking Member Committee on Energy and Commerce Washington, DC
May 24, 2012 Blumenthal Hails Senate Passage of the FDA Safety and Innovation Act, Highlights Key Consumer Provisions He Introduced Washington, DC
May 22, 2012 Kohl, Grassley and Blumenthal Seek to Cut Misuse of Antipsychotics Washington, DC
May 2, 2012 Senators Respond to New Data on Tobacco Tax Loophole Washington, DC
March 30, 2012 Blumenthal Applauds New Food and Drug Administration Guidelines on Big Tobacco Washington, DC
March 29, 2012 Blumenthal, Corker, Gingrey Praise Inclusion of GAIN Act in Discussion Draft of Food and Drug Administration User Fee Reauthorization Bill Washington, DC
March 9, 2012 Letter to John T. Standley, President Chief Executive Officer of Rite Aid Pharmacy Hartford, CT
March 8, 2012 Letter to Mr. John T. Standley, President and Chief Executive Officer, Rite Aid Pharmacy Washington, DC
March 8, 2012 Senators: Surgeon General's Report on Youth Smoking Epidemic a Call to Action For State and Federal Government Washington, DC
March 7, 2012 Letter to Margaret Hamburg, Commissioner of the Food and Drug Administration Hartford, CT
Feb. 17, 2012 Letter to George Doyle III, President and Chief Operating Officer of Ben Venue Laboratories Washington, DC
Feb. 16, 2012 Letter to George Doyle III, President and Chief Operating Officer of Ben Venue Laboratories Washington, DC
Feb. 8, 2012 The Hill - Innovation Key to Fighting 'SuperBugs' Washington, DC
Feb. 1, 2012 Mikulski, Senate And House Leaders, Introduce Bipartisan Legislation To Fight Chronic Health Conditions Washington, DC
Jan. 26, 2012 Citizens United Anniversary Washington, DC
Jan. 17, 2012 Blumenthal Statement on Disclosure of Drug Company Payments to Doctors Hartford, CT
Jan. 4, 2012 Blumenthal Drug Shortage Survey Exposes Damaging Effects in CT Hartford, CT
Dec. 22, 2011 Letter to Mark Emmert, President, The National Collegiate Athletic Association Unknown
Dec. 16, 2011 Feinstein, Grassley Bill to Combat Transnational Organized Crime Passes the Senate Washington, DC
Dec. 15, 2011 Letter to The Honorable Margaret Hamburg, Commissioner Food and Drug Administration Washington, DC
Dec. 15, 2011 New GAO Report Blumenthal Requested Reveals Growing Number of Life Threatening Drug Shortages Washington, DC
Dec. 8, 2011 Statement on Judiciary Committee Approval and Passage of Counterfeit Drug Legislation Washington, DC
Nov. 30, 2011 Blumenthal Calls for End to Over Prescription of Antipsychotic Drugs in Nursing Homes Washington, DC
Nov. 17, 2011 Proposal for Bipartisan, Bicameral Bill To Increase Penalties For Counterfeit Drugs Washington, DC
Nov. 17, 2011 Meehan Introduces Bill Boosting Penalties for Rx Drug Counterfeiting Washington, DC
Nov. 2, 2011 Rebuild America Jobs Act Washington, DC
Oct. 31, 2011 Blumenthal Praises President's Executive Order to Address Drug Shortage Crisis Washington, DC
Oct. 21, 2011 Blumenthal Applauds DEA Decision to Put Bath Salts on Controlled Substances List Hartford, CT
Oct. 14, 2011 Letter to Mary Hamburg, Commisioner of the Food and Drug Administration Washington, DC
Sept. 26, 2011 Letter to Secretary Sebelius, Health and Human Services Washington, DC
July 21, 2011 Blumenthal Calls for Measures to Lower Drug Prices for Seniors Washington DC
July 8, 2011 Blumenthal Visits Connecticut Children's Medical Center to Discuss Threat of Drug Resistant Infections Washington DC
June 16, 2011 Letter to The Honorable Margaret Hamburg, Commissioner, Food and Drug Administration Washington, DC
May 4, 2011 Letter to Mr. Gene L. Dodaro, Comptroller, U.S. Government Accountability Office (GAO) Washington, DC
April 18, 2011 Letter to Margaret Hamburg, Commissioner of the Food and Drug Administration Hartford, CT
Issue Position: Seniors Unknown
Issue Position: Health Care Unknown

About Project Vote Smart

Help Us If You Can

Media & Communications

Education

For Candidates

One Common Ground, Philipsburg, MT 59858 Hotline: 888-Vote-Smart (888-868-3762)
All content © 1992 - 2013 Project Vote Smart unless otherwise attributed - Privacy Policy - Legislative demographic data provided by Aristotle International, Inc. Mobile Version

Back to top